Medicine and Dentistry
1 Methyladenosine
100%
Nucleoside
83%
Pseudouridine
83%
Lymphocyte
66%
Ribosome RNA
66%
Blood
66%
Stimulation
33%
Malignant Neoplasm
33%
Tumor Cell Line
33%
Phytohaemagglutinin
33%
Patient
33%
Analysis
33%
Monoclonal Antibody
16%
Tumor Cell
16%
Flow Cytometry
16%
DNA Synthesis
16%
Urinary Excretion
16%
Immunofluorescence Test
16%
Tumor Marker
16%
DNA Determination
16%
Sulfhemoglobinemia
16%
Kidney Concentrating Capacity
16%
Cells
16%
Cell Line
16%
Chemistry
1-Methyladenosine
100%
Nucleoside
83%
Pseudouridine
83%
Ribosomal RNA
66%
Analytical Method
50%
Flow
50%
Deoxyribonucleic Acid
33%
Concentration
33%
Monoclonals
16%
Cytometry
16%
Tumor Marker
16%
Haematological
16%
Spectra
16%
Synthesis (Chemical)
16%
Pharmacology, Toxicology and Pharmaceutical Science
1 Methyladenosine
100%
Nucleoside
83%
Pseudouridine
83%
Ribosome RNA
66%
Malignant Neoplasm
33%
Chemotherapy
33%
Phytohemagglutinin
33%
Normal Human
16%
Monoclonal Antibody
16%
Tumor Marker
16%
Hematologic Disease
16%
Biochemistry, Genetics and Molecular Biology
Nucleoside
83%
Pseudouridine
83%
Peripheral Blood Lymphocyte
66%
Ribosomal RNA
66%
Flow
33%
Normal Human
16%
Flow Cytometry
16%
Monoclonal Antibodies
16%
DNA Synthesis
16%
Kidney Concentrating Capacity
16%
Spectrum
16%
Tumor Marker
16%
Urinary Excretion
16%
DNA Analysis
16%
Phytohaemagglutinin
16%
Immunology and Microbiology
Peripheral Blood Lymphocyte
66%
Phytohemagglutinin
33%
Tumor Cell Line
33%
Flow
33%
Normal Human
16%
Tumor Cell
16%
Staining
16%
DNA Synthesis
16%
Spectrum
16%
Urinary Excretion
16%
Kidney Concentrating Capacity
16%
Cells
16%